ADx will attend CTAD 2024

ADx is excited to attend CTAD 2024!

Eugeen will share his expertise and talk about the relevance of synaptic biomarkers in various neurological diseases, highlighting their potential impact on advancing research and treatment.

Alongside our collaborators and the Fujirebio Group, we’ll be presenting a range of interesting topics. Don’t miss the chance to explore these and check out the details below!